Zehra Yonel

Medicine & Life Sciences

1. alpha 1-Antitrypsin Deficiency 21%
2. Alveolar Bone Loss 14%
3. Biomarkers 10%
4. Chronic Obstructive Pulmonary Disease 20%
5. Clinical Chemistry 21%
6. Cross-Sectional Studies 13%
7. Data Management 10%
8. Delivery of Health Care 18%
9. Dental Care 16%
10. Dental General Practices 24%
11. Dentistry 17%
12. Education 10%
13. Equipment and Supplies 12%
14. Flumazenil 22%
15. Gingival Crevicular Fluid 22%
16. Gingivitis 46%
17. Head 12%
18. Health 21%
19. Health Status 14%
20. Hormones 11%
21. Human Activities 16%
22. Hyperglycemia 49%
23. Immunoglobulin A 15%
24. Light 11%
25. mesoglycan 14%
26. Microbiota 16%
27. Neutrophils 18%
28. Noncommunicable Diseases 66%
29. Oral Health 24%
30. Pathology 10%
31. Patient Care Team 19%
32. Patient Reported Outcome Measures 36%
33. Peptide Hydrolases 13%
34. Periodontitis 44%
35. Pharmacies 44%
36. Pharmacists 20%
37. Pharmacy 26%
38. Point-of-Care Testing 30%
39. Prediabetic State 17%
40. Primary Health Care 12%
41. Publications 13%
42. Quality of Life 11%
43. Rheumatoid Arthritis 27%
44. Risk Assessment 28%
45. Saliva 33%
46. Steroids 12%
47. Systematic Reviews 50%
48. Systemic Hyalinosis 29%
49. Tooth 100%
50. Type 2 Diabetes Mellitus 50%